Topics of Interest

Increased Risk of Lymphoma and Other Cancers Associated With the Use of Tumor Necrosis Factor (TNF) Blockers(marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi)

تحديث معلومات السلامة الدوائية الخاصة بعقار انسولين قلارجين (Insulin glargine, Lantus®)

انخفاض عدد كريات الدم الحمراء أحد عوامل الخطر في وفاة المسنين

Diabetes drug Avandia comes under new criticism

Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy

Study reports first successful drug treatment of tumors in NF2 patients.

Early Communication About Safety of Lantus (insulin glargine)

Updated Labeling for Piroxicam – Drug No Longer to be Used for Acute Pain or Inflammation

Reports of pure red cell aplasia in patients treated with CellCept® (mycophenolate mofetil)